Skip to main content

Table 2 1-, 2-, 5-, and 10-year incidence of bone metastases by tumor type

From: Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States

Tumor type

Incidence of bone metastases (%)

1-year (95% CI)

2-year (95% CI)

5-year (95% CI)

10-year (95% CI)

All tumor types combined (N = 382,733)

4.8 (4.7–4.8)

5.6 (5.5–5.6)

6.9 (6.8–7.0)

8.4 (8.3–8.5)

Breast (N = 137,720)

3.4 (3.3–3.5)

4.2 (4.1–4.3)

6.0 (5.8–6.1)

8.1 (7.9–8.3)

Prostate (N = 22,801)

18.0 (17.5–18.5)

20.4 (19.9–20.9)

24.5 (23.9–25.1)

29.2 (28.3–30.1)

Lung (N = 59,344)

10.4 (10.2–10.7)

11.5 (11.3–11.8)

12.4 (12.1–12.7)

12.9 (12.6–13.2)

Colorectal (N = 46,832)

1.0 (0.9–1.1)

1.4 (1.3–1.5)

2.1 (2.0–2.3)

2.7 (2.5–2.9)

Gastrointestinal (N = 32,874)

2.3 (2.1–2.5)

2.7 (2.6–2.9)

3.2 (3.0–3.4)

3.6 (3.3–3.8)

Gynecological (N = 21,075)

1.1 (0.9–1.2)

1.3 (1.2–1.5)

1.9 (1.7–2.1)

2.4 (2.1–2.7)

Malignant melanoma (N = 12,152)

1.6 (1.4–1.8)

2.0 (1.7–2.2)

2.5 (2.2–2.8)

3.0 (2.6–3.4)

Renal (N = 17,717)

5.8 (5.5–6.2)

6.9 (6.6–7.3)

8.4 (8.0–8.9)

9.9 (9.3–10.5)

All other tumors (N = 32,218)

2.0 (1.8–2.1)

2.5 (2.3–2.7)

3.2 (3.0–3.4)

3.9 (3.5–4.2)